Seoul National University Hospital
Seoul, Seoul Teugbyeolsi [Seoul-T'ukpyolshi] 03080
1 studies enrolling now · 2 studies all time
What they study most
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma
Studies at this site
- A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation. — Recruiting now
- A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10) — Stopped early